(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
2.96% ¥ 2 593.50
Live Chart Being Loaded With Signals
AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally...
Stats | |
---|---|
Объем за сегодня | 189 200 |
Средний объем | 118 446 |
Рыночная капитализация | 187.79B |
EPS | ¥0 ( 2024-01-30 ) |
Дата следующего отчета о доходах | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥63.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 24.46 |
ATR14 | ¥2.07 (0.08%) |
Объем Корреляция
AS ONE Corporation Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
AS ONE Corporation Корреляция - Валюта/Сырье
AS ONE Corporation Финансовые показатели
Annual | 2022 |
Выручка: | ¥91.42B |
Валовая прибыль: | ¥28.45B (31.12 %) |
EPS: | ¥109.45 |
FY | 2022 |
Выручка: | ¥91.42B |
Валовая прибыль: | ¥28.45B (31.12 %) |
EPS: | ¥109.45 |
FY | 2022 |
Выручка: | ¥86.95B |
Валовая прибыль: | ¥25.54B (29.38 %) |
EPS: | ¥192.68 |
FY | 2021 |
Выручка: | ¥81.61B |
Валовая прибыль: | ¥25.93B (31.77 %) |
EPS: | ¥160.06 |
Financial Reports:
No articles found.
AS ONE Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥48.00 (N/A) |
¥0 (N/A) |
¥63.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥4.55 | 2001-03-27 |
Last Dividend | ¥63.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥805.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.1 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.40 | |
Div. Directional Score | 8.80 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8140.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7494.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6718.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6062.T | Ex Dividend Knight | 2024-06-27 | Annually | 0 | 0.00% | |
4743.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
3984.T | Ex Dividend Junior | 2024-06-27 | Annually | 0 | 0.00% | |
3193.T | Ex Dividend Junior | 2024-01-30 | Annually | 0 | 0.00% | |
2183.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9058.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7944.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0818 | 1.500 | 8.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0817 | 1.200 | 7.28 | 8.73 | [0 - 0.3] |
returnOnEquityTTM | 0.120 | 1.500 | 9.78 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.49 | 0.800 | 2.56 | 2.05 | [1 - 3] |
quickRatioTTM | 1.974 | 0.800 | 3.10 | 2.48 | [0.8 - 2.5] |
cashRatioTTM | 0.592 | 1.500 | 7.82 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0456 | -1.500 | 9.24 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 2 336.16 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 48.98 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 48.98 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0661 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.309 | 1.000 | 8.19 | 8.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.114 | 1.000 | 9.73 | 9.73 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.825 | 1.000 | 6.53 | 6.53 | [0.2 - 2] |
assetTurnoverTTM | 0.999 | 0.800 | 6.67 | 5.34 | [0.5 - 2] |
Total Score | 12.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.37 | 1.000 | 7.64 | 0 | [1 - 100] |
returnOnEquityTTM | 0.120 | 2.50 | 9.86 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 48.98 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.12 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 48.98 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.206 | 1.500 | 5.30 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0377 | 1.000 | -1.558 | 0 | [0.1 - 0.5] |
Total Score | 5.40 |
AS ONE Corporation
AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally. It offers scientific instruments comprising temperature/humidity control and measuring/surveying instruments, as well as universal products used for cooling, heating, mixing, absorption, pressurization, and conveyance; microscopes, glass slides, and tissue culture products for biotechnology; magnifying glasses indispensable for precision work, plus filters, and dispensing devices required for analysis technology; equipment indispensable for research facilities, such as experimental platforms, fume hoods, and pharmaceutical depositories, as well as storage equipment, wagons, laboratory chairs, and conveyance equipment; containers required for storage or preservation of samples, reagents, materials, and others; glass or plastic beakers, flask indispensables, hoses, tubes, and joints; tapes and labels; and timers, packaging machines, tools, office supplies, and other equipment for laboratories. The company also provides industrial instruments, such as dehumidifying storage products; equipment for organization, conveyance, etc.; equipment for sterilization/disinfecting and cleaning, including ultrasonic cleaners for washing/drying, detergents, and drying tools; glasses, masks, and gloves; and tools and containers used in clean rooms, as well as dust-proof and anti-static products comprising clean room clothes and mats indispensable. In addition, it offers hospital/nursing instruments, such as white gowns, masks, and gloves; rack systems to be installed in nursing stations; various products, supplies, and equipment required for hospital nursing or care; and sterilizers and sterilization lockers, as well as care cars and beds, and bathing and sanitary products. The company was founded in 1933 and is headquartered in Osaka, Japan.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа